Davoren AK, Rulison K, Milroy J, Grist P, Fedoruk M, Lewis L, et al
FDA approved semaglutide injection (once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol etc), for use in addition to a diet and increased physical activity
Dosing errors are the most common documented category
Your healthcare provider will prescribe a lower starting dosage and then gradually increase your dosage over a period of 5 20 weeks
Therefore, regular eye examination and follow-ups are recommended to reduce the risk of worsening diabetic retinopathy and blurred vision
In clinical trials, it took 68 weeks for the average study participant to lose 33 pounds on a 2.4mg dose of semaglutide, the active ingredient in Ozempic